Ramon Visit 1: A 65-year-old man with cardiometabolic risk factors

Title:

Ramon Visit 1: A 65-year-old man with cardiometabolic risk factors

Topic: Endocrinology
Relevant Terms: Diabetes, Dyslipidemia, Hypertension, Obesity
Primary Audience: Primary care providers including physicians; physician assistants; and nurse practitioners
Launch Date: 13-Aug-13
Credits: 0.75 AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Hitting the Sweet Spot in the Primary Care Setting: Treating Patients with Diabetes to...

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Develop stepwise treatment plans to attain glycemic goals and manage microvascular complications
  2. Employ 2013 ADA Standards of Care to individualize treatment plans for older patients with diabetes in order to improve glycemic control
  3. Incorporate rational use of new diabetic pharmacotherapy with more established therapies in order to address the individual needs of patients with diabetes
  4. Reduce clinical inertia by intensifying therapy for patients who are not at their glycemic goal, as recommended by 2013 ADA Standards of Care
  5. Incorporate additional considerations when developing treatment plans for patients with diabetes in order to improve long-term outcomes

    Faculty

    Silvio E. Inzucchi, MD
    Professor of Medicine
    Yale University School of Medicine
    Department of Endocrinology and Metabolism
    Director, Yale Diabetes Center
    New Haven, CT
    Louis Kuritzky, MD
    Assistant Professor
    Department of Medicine – Community Health and Family Medicine
    University of Florida
    Gainesville, FL
    Anne Peters, MD
    Professor of Medicine
    Keck School of Medicine of the University of Southern California
    Division of Endocrinology
    Director of the USC Clinical Diabetes Programs
    Los Angeles, CA
    PROGRAM OVERVIEW:
    Patients with diabetes are commonly identified and treated based on screening physical examinations, which allows physicians to have a large impact on their future health and lives. At this time, however, problems in the care of diabetes frequently lead to suboptimal management of diabetes. Doctors at the forefront of diabetes care require continued efforts on the part of education providers to learn the latest in scientific and therapeutic management of diabetes. Helping them overcome gaps in care will provide a significant end-benefit to patient with diabetes.
     
    CME Advisory Committee
     
    Course Director/Course Reviewer
     
    Katherine Galluzzi, DO, CMD, FACOFP dist.
    Professor and Chairperson, Department of Geriatrics
    Philadelphia College of Osteopathic Medicine
    Attending Physician, Family Medicine
    Tenet Roxborough Memorial Hospital
    Philadelphia, PA
      
    Planning Committee
     
    Kelly Kraines
    General Manager
    Med Learning Group
     
    Joshua Kilbridge
    President
    Kilbridge Associates
    Healthcare Communications
     
    DISCLOSURE POLICY STATEMENT:
    In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor.  All faculty, authors, editors, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
     
    DISCLOSURE OF CONFLICTS OF INTEREST:
     
    Faculty
    Silvio E. Inzucchi, MD
    Disclosure: Dr. Inzucchi has served as an advisor to Boehringer Ingelheim, Bristol-Myers Squibb, Janssen Pharmaceuticals, Inc., and Merck & Co., Inc.  He is a member of data safety monitoring boards for clinical trials being sponsored by Novo Nordisk and Gilead.  He is a co-investigator on a clinical trial funded by the National Institutes of Health, for which Takeda Pharmaceuticals is providing study drug.
     
    Louis Kuritzky, MD
    Disclosure: Dr. Kuritzky receives consulting fees from Boehringer Ingelheim, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Novo Nordisk, and Sanofi.
     
    Anne Peters, MD
    Disclosure: Dr. Peter receives consulting fees from Eli Lilly and Company/ Boehringer Ingelheim, Abbott Diabetes Care, BD, Janssen Pharmaceuticals, Inc, Medtronic, Inc., Perrigo, Roche, Sanofi, Takeda Pharmaceuticals Company.  She is on the speakers' bureaus for Bristol-Myers Squibb/AstraZeneca and Novo Nordisk.
     
    Katherine Galluzzi, DO, CMD, FACOFP dist.
    Disclosure: Dr. Galluzzi has no relevant financial relationships to disclose.
     
    Planning Committee
    The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
     
    Kelly Kraines of Med Learning Group has no relevant financial relationships to disclose.
     
    Joshua Kilbridge of Kilbridge Associates has no relevant financial relationships to disclose.
     
     
    ACCREDITATION STATEMENT:
    Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
     
    This CME activity was planned and produced in accordance with the ACCME Essentials.
    For CME questions, please contact: Med Learning Group at info@medlearninggroup.com
    Contact this CME provider for privacy and confidentiality policy statement information at:
    http://www.medlearninggroup.com/privacy-policy/
     
    CREDIT DESIGNATION STATEMENT:
    Med Learning Group designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
     
    TO OBTAIN CME CREDITS:
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the post-test and activity evaluation.
    • Physicians who successfully complete the post-test and evaluation will receive CME credit.
    • You must score 70% or higher on the post-test to receive credit for this activity.
    • All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
    COURSE VIEWING REQUIREMENTS
    Supported Browsers:
    Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
    Google Chrome 18.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 13.0+ for Windows, Mac OS, or Linux
    Safari 4.0+ for Mac OSX 10.5 and above
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above
     

    DISCLAIMER: 
    Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
     
    DISCLOSURE OF UNLABLED USE:
    Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

    Release Date: August 13, 2013
    Expiration Date: August 12, 2014
     
    MEDIUM: Internet
     
    ACKNOWLEDGEMENT:
    This activity is sponsored by Med Learning Group.
                                              
    This activity is supported by an educational grant from Lilly USA, LLC.
                       
    If you have any questions regarding this activity, send an email to info@medlearninggroup.com.
     
    This educational activity provides training necessary for licensed attendees to maintain state licensing requirements. The tuition for this educational activity is subsidized in part by unrestricted educational grants, including for those attendees who have successfully completed the state licensing requirements for their respective fields.  
     
    Copyright © 2013 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.